{"id":546078,"date":"2021-06-03T18:36:01","date_gmt":"2021-06-03T18:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=546078"},"modified":"2021-06-03T18:36:01","modified_gmt":"2021-06-03T18:36:01","slug":"prefilled-syringes-market-worth-86-billion-by-2025-key-players-are-gerresheimer-germany-schott-ag-germany","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/prefilled-syringes-market-worth-86-billion-by-2025-key-players-are-gerresheimer-germany-schott-ag-germany_546078.html","title":{"rendered":"Prefilled Syringes Market worth $8.6 billion by 2025 | Key Players are Gerresheimer (Germany), SCHOTT AG (Germany)"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1622722490.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Prefilled Syringes Market worth $8.6 billion by 2025 | Key Players are Gerresheimer (Germany), SCHOTT AG (Germany)\" src=\"https:\/\/www.abnewswire.com\/uploads\/1622722490.jpeg\" alt=\"Prefilled Syringes Market worth $8.6 billion by 2025 | Key Players are Gerresheimer (Germany), SCHOTT AG (Germany)\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Key Players in Prefilled Syringes Market are Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan).<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Prefilled Syringes Market Industry Segments, Opportunities, Growth, Size and Key Players Analysis.<\/div>\n<p style=\"text-align: justify;\">According to the new market research report&nbsp;<strong>&#8220;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/prefilled-syringes-market-16618331.html?utm_source=prnewswire&amp;utm_medium=referral&amp;utm_campaign=paidpr\" rel=\"nofollow noopener\" target=\"_blank\">Prefilled Syringes Market<\/a><strong>&nbsp;by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) &#8211; Global Forecast to 2025&#8243;,&nbsp;<\/strong>published by MarketsandMarkets&trade;,<strong>&nbsp;<\/strong>is estimated to be&nbsp;<span class=\"xn-money\">USD 5.6 billion<\/span>&nbsp;in 2020 and projected to reach&nbsp;<span class=\"xn-money\">USD 8.6 billion<\/span>&nbsp;by 2025, at a CAGR of 9.0%.<\/p>\n<p>The Rising target disease population, rapid growth in generic products, rising adoption of self-medication and digitalization, affordable cost with increased efficiency, and technological advancements are the major factors driving the growth of the market. Furthermore, growing initiatives undertaken by leading market players to establish production facilities in both mature and developing markets are the key factors driving the growth of the prefilled syringes industry.<\/p>\n<p><em>Browse&nbsp;and in-depth TOC on<\/em><strong>&nbsp;&#8220;<\/strong><strong>Prefilled Syringes Market<\/strong><strong>&#8220;<\/p>\n<p><\/strong><strong>104 &#8211; Tables<br \/><\/strong><strong>30 &#8211; Figures<br \/><\/strong><strong>149 &#8211; Pages<\/p>\n<p><\/strong><strong>Download PDF Brochure:&nbsp;<\/strong><br \/><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=16618331&amp;utm_source=prnewswire&amp;utm_medium=referral&amp;utm_campaign=paidpr\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=16618331<\/a><\/p>\n<p>The Prefilled Syringes Market includes major Tier I and II suppliers like Becton, Dickinson and Company (US), Gerresheimer (<span class=\"xn-location\">Germany<\/span>),&nbsp;<span class=\"xn-person\">SCHOTT AG<\/span>&nbsp;(<span class=\"xn-location\">Germany<\/span>), and West Pharmaceutical Services, Inc. (US), and Nipro Corporation (<span class=\"xn-location\">Japan<\/span>). These suppliers have their manufacturing facilities spread across regions such as&nbsp;<span class=\"xn-location\">North America<\/span>&nbsp;and&nbsp;<span class=\"xn-location\">Europe<\/span>. COVID-19 has impacted their businesses as well. Routine care for chronic diseases is an ongoing challenge amidst the global COVID-19 pandemic due to the change in routine care to virtual communication. Diabetes, chronic obstructive pulmonary disease, and hypertension were the most impacted conditions due to a reduction in access to care. Furthermore, currently, most global healthcare resources are focused on coronavirus disease (COVID-19), and this resource reallocation is expected to disrupt the continuum of care for patients with chronic diseases.<\/p>\n<p><a title=\"Prefilled Syringes market\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/prefilled-syringes-market-16618331.html\"><img decoding=\"async\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/SamirS\/prefilled-syringes-market5.jpg?1622722730518\" alt=\"prefilled-syringes-market5\" \/><\/a><\/p>\n<p><strong>Increasing adoption of self-administered injectable drugs is expected to result in the segment occupying the majority of the market share<\/p>\n<p><\/strong>The conventional Prefilled Syringes Market is estimated to have the largest market share by value. Growth of this segment can be attributed to the the advantages offered, such as safe administration, ease of use for both healthcare professionals and end users, reduced risk of contamination of the product, less waste of costly API, ease of manufacturing, improved dosing accuracy, and enhanced product differentiation when compared to vials is expected to drive the market growth.<\/p>\n<p><strong>Plastic Prefilled Syringes estimated to be the fastest-growing market<\/p>\n<p><\/strong>Plastic prefilled syringes are estimated to be the fastest-growing segment in the Prefilled Syringes Market. The growth of this segment can be attributed to the rising development of newer polymers (which possess various physical and chemical properties such as high heat &amp; break resistance, tolerance of freeze-drying &amp; liquid nitrogen exposure, high transparency, and solvent resistance.<\/p>\n<p><span class=\"xn-location\">Europe<\/span>&nbsp;is estimated to be the largest market due to the rising prevalence of chronic diseases, growth of the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, aging population, and high adoption of self-injection devices are driving the demand for self-injectable prefilled syringes.<\/p>\n<p><strong>Request Sample Report:&nbsp;<br \/><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=16618331\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=16618331<\/a>&nbsp;<\/p>\n<p><\/strong><strong><span class=\"xn-location\">Asia Pacific<\/span>&nbsp;likely to emerge as the largest Prefilled Syringes Market, globally<\/p>\n<p><\/strong><span class=\"xn-location\">Asia Pacific<\/span>&nbsp;is estimated to be the fastest-growing market for prefilled syringes during the forecast period. The&nbsp;<span class=\"xn-location\">Asia Pacific<\/span>&nbsp;market is driven principally by the increasing demand for self-administered treatments, high penetration of self-injection devices, growing aging population, increasing prevalence of diabetes, and huge patient population.<\/p>\n<p>Becton, Dickinson and Company (US), Gerresheimer (<span class=\"xn-location\">Germany<\/span>),&nbsp;<span class=\"xn-person\">SCHOTT AG<\/span>&nbsp;(<span class=\"xn-location\">Germany<\/span>), and West Pharmaceutical Services, Inc. (US) are the key players in the global&nbsp;<strong>Prefilled Syringes Market<\/strong>.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=prefilled-syringes-market-worth-86-billion-by-2025-key-players-are-gerresheimer-germany-schott-ag-germany\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/prefilled-syringes-market-16618331.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/prefilled-syringes-market-16618331.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/prefilled-syringes-market-16618331.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=prefilled-syringes-market-worth-86-billion-by-2025-key-players-are-gerresheimer-germany-schott-ag-germany\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Players in Prefilled Syringes Market are Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/prefilled-syringes-market-worth-86-billion-by-2025-key-players-are-gerresheimer-germany-schott-ag-germany_546078.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,404],"tags":[],"class_list":["post-546078","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/546078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=546078"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/546078\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=546078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=546078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=546078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}